文献速递肿瘤 PET/CT核素与放射性配体治疗

68Ga-PSMA PET/CT在前列腺癌复发中的应用:注射后60分钟显像阴性时是否应进行延迟显像?

68Ga-PSMA PET/CT in Recurrence Prostate Cancer. Should We Perform Delayed Image in Cases of Negative 60 Minutes Postinjection Examination?
PubMed 文献 · Clin Nucl Med · 2020-01-01

本文报告一例59岁前列腺腺癌患者,Gleason评分9,前列腺切除术后及辅助放疗后出现生化复发。标准68Ga-PSMA PET/CT注射后60分钟显像仅见输尿管微量摄取,注射后2小时延迟盆腔显像清晰显示右侧髂内淋巴结摄取增高(CT上大小正常),据此制定放疗计划,随访前列腺特异性抗原降至0.04 ng/mL。

要点

  • 标准60分钟68Ga-PSMA PET/CT显像阴性时,延迟2小时盆腔显像可能有助于识别靠近输尿管的病灶。
  • 延迟显像可清晰显示CT上大小正常的右侧髂内淋巴结摄取增高。
  • 基于68Ga-PSMA PET/CT图像制定放疗计划后,随访前列腺特异性抗原降至0.04 ng/mL。

核心结论

  • 在标准60分钟68Ga-PSMA PET/CT显像仅见输尿管微量摄取的病例中,注射后2小时延迟盆腔显像清晰显示了右侧髂内淋巴结摄取增高。

研究设计与样本

  • 本文为病例报告,报告一例59岁前列腺腺癌患者,Gleason评分9,前列腺切除术后及辅助放疗后出现生化复发。

主要发现

  • 标准68Ga-PSMA PET/CT注射后60分钟显像仅见输尿管微量摄取。
  • 注射后2小时延迟盆腔显像清晰显示右侧髂内淋巴结摄取增高,该淋巴结在CT上大小正常。
  • 患者基于68Ga-PSMA PET/CT图像制定放疗计划并接受放疗,随访前列腺特异性抗原降至0.04 ng/mL。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We report a case of a 59-year-old man with prostate adenocarcinoma, Gleason score 9 after prostatectomy and adjuvant radiotherapy. The patient showed biochemical recurrence. On standard Ga-PSMA PET/CT examination, 60 minutes postinjection, the PET/CT images showed only trace accumulation in the ureters. To identify lesions close to the ureters, imaging of the pelvis was performed 2 hours postinjection. The delayed image showed clearly visible increased uptake in a right internal iliac lymph node that was normal-sized by CT. The patient underwent radiotherapy with planning based on the Ga-PSMA PET/CT image. Follow-up testing showed prostate-specific antigen level reduction to 0.04 ng/mL.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Kunikowska J, Kujda S, Królicki L, et al. 68Ga-PSMA PET/CT in Recurrence Prostate Cancer. Should We Perform Delayed Image in Cases of Negative 60 Minutes Postinjection Examination? Clin Nucl Med. 2020. PMID: 32049736. doi:10.1097/RLU.0000000000002966

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。